Epidemiology of Myocarditis and Pericarditis Following mRNA Vaccination by Vaccine Product, Schedule, and Interdose Interval Among Adolescents and Adults in Ontario, Canada | Adolescent Medicine | JAMA Network Open | JAMA Network
This cohort study estimates rates of myocarditis and pericarditis after receipt of an mRNA COVID-19 vaccine among individuals in Ontario, Canada, stratified by
Ein hervorragender thread dazu von @TracyBethHoeg:
🇨🇦Ontario reporting the highest rate of post vaccination myocarditis I've seen:
— Tracy Høeg, MD, PhD (@TracyBethHoeg) June 26, 2022
1/1287 (777/mill) in males 18-24 if they received Pfizer then Moderna within 30 days
Moderna >6x higher risk of myo than pfizer
This & the new study from France discussed 🧵https://t.co/w8CTEAIhCN pic.twitter.com/ifblwJJbft